|
|||||
|
|
Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies |
|
| Authors: | Gary Ong Michael Manyak Zrinka Lulic |
| Affiliation: | 1. GlaxoSmithKline, Research &2. Development, Brentford, UK;3. Development, Research Triangle Park, North Carolina, USA |
| Abstract: | |
| Keywords: | |